Erythromycin: Broad-Spectrum Antibiotic for Bacterial Infection Control
| Product dosage: 250mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 90 | $0.55 | $49.31 (0%) | 🛒 Add to cart |
| 120 | $0.50 | $65.75 $60.38 (8%) | 🛒 Add to cart |
| 180 | $0.47 | $98.62 $84.53 (14%) | 🛒 Add to cart |
| 270 | $0.44 | $147.94 $118.75 (20%) | 🛒 Add to cart |
| 360 | $0.43
Best per pill | $197.25 $153.97 (22%) | 🛒 Add to cart |
Erythromycin is a macrolide-class antibiotic with established efficacy against a wide range of gram-positive and some gram-negative bacteria. It functions by inhibiting bacterial protein synthesis, effectively halting microbial replication. This medication is particularly valuable for patients with penicillin allergies and remains a cornerstone in treating respiratory, skin, and soft tissue infections. Its versatile formulation options—including oral tablets, topical solutions, and intravenous administration—ensure tailored therapeutic approaches across diverse clinical scenarios.
Features
- Belongs to the macrolide antibiotic class
- Available in multiple formulations: tablets, capsules, ointments, gels, and intravenous solutions
- Bacteriostatic mechanism: inhibits protein synthesis by binding to the 50S ribosomal subunit
- Effective against Streptococcus, Staphylococcus, Mycoplasma, and Chlamydia species
- Some extended-release formulations allow for less frequent dosing
Benefits
- Provides a reliable alternative for patients with penicillin hypersensitivity
- Effective against atypical pathogens often resistant to other first-line antibiotics
- Topical formulations minimize systemic exposure while targeting localized skin infections
- Oral and IV options allow for flexible treatment scaling based on infection severity
- Established safety profile with decades of clinical use and research
Common use
Erythromycin is commonly prescribed for bacterial infections including streptococcal pharyngitis, community-acquired pneumonia, pertussis (whooping cough), and skin infections like erysipelas or impetigo. It is also used prophylactically to prevent endocarditis in high-risk patients undergoing dental procedures and for gastrointestinal motility stimulation in certain off-label applications. Ophthalmologic preparations treat conjunctivitis and blepharitis, while topical formulations address acne vulgaris.
Dosage and direction
Dosage varies significantly based on formulation and indication. For adults, typical oral doses range from 250 mg to 1 g every 6-12 hours, not exceeding 4 g daily. Pediatric dosing is weight-based at 30-50 mg/kg/day divided into 3-4 doses. Intravenous administration is reserved for severe infections at 15-20 mg/kg/day. Topical applications involve thin layers applied to affected areas twice daily. Always complete the full prescribed course even if symptoms improve earlier. Take oral doses with food to minimize gastrointestinal upset unless directed otherwise.
Precautions
Use with caution in patients with hepatic impairment due to erythromycin’s extensive liver metabolism. Periodic liver function tests are recommended during prolonged therapy. May prolong QT interval—avoid in patients with known arrhythmias or concomitant use of other QT-prolonging drugs. Superinfections including Clostridium difficile-associated diarrhea may occur. Not recommended during pregnancy unless clearly needed (Category B). Excreted in breast milk; consider alternative feeding options during treatment.
Contraindications
Hypersensitivity to erythromycin or other macrolide antibiotics. Contraindicated in patients taking cisapride, pimozide, or ergot derivatives due to potentially fatal drug interactions. Avoid use in patients with pre-existing cardiac conditions involving QT prolongation or history of ventricular arrhythmias. Severe hepatic impairment constitutes a contraindication for systemic formulations.
Possible side effect
Common: nausea, vomiting, abdominal pain, diarrhea, loss of appetite. Less frequent: reversible hearing loss (especially at high doses), hepatic enzyme elevations, allergic skin reactions. Rare but serious: QT prolongation, torsades de pointes, cholestatic hepatitis, pseudomembranous colitis. Topical applications may cause drying, peeling, or irritation at application site. Ophthalmic preparations might cause temporary blurred vision or eye irritation.
Drug interaction
Erythromycin significantly inhibits CYP3A4 metabolism, increasing concentrations of: warfarin (monitor INR), theophylline, carbamazepine, digoxin, statins, and many benzodiazepines. Contraindicated with cisapride, pimozide, ergotamine, and dihydroergotamine. May reduce efficacy of oral contraceptives—recommend backup contraception. Potentiates effects of non-depolarizing muscle relaxants. Antacids containing aluminum or magnesium may decrease absorption.
Missed dose
Take the missed dose as soon as remembered unless it’s nearly time for the next scheduled dose. Do not double the dose to compensate for a missed one. Maintaining consistent antibiotic levels is crucial for efficacy, but occasional slight delays are preferable to dose duplication. For multiple daily dosing regimens, if remembered within 4 hours of the next dose, skip the missed dose entirely.
Overdose
Symptoms may include severe nausea, vomiting, diarrhea, hearing loss, and hepatic dysfunction. QT prolongation and ventricular arrhythmias may occur in massive overdoses. Treatment is supportive: gastric lavage if presented early, activated charcoal if appropriate, and cardiac monitoring. Hemodialysis is not effective due to high protein binding and extensive tissue distribution. Contact poison control center (1-800-222-1222) or emergency services immediately.
Storage
Store at room temperature (15-30°C/59-86°F) in original container away from light and moisture. Do not freeze liquid suspensions. Keep all medications out of reach of children and pets. Discard unused oral suspension after 14 days. Do not flush medications; consult pharmacy for proper disposal methods.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Always consult a healthcare professional for diagnosis and treatment decisions. Dosage and indications may vary based on individual patient factors, local guidelines, and emerging clinical evidence. Not all side effects or interactions are listed here.
Reviews
“Erythromycin remains our go-to macrolide for community-acquired pneumonia in penicillin-allergic patients. The IV formulation is particularly valuable in hospital settings.” - Infectious Disease Specialist, 15 years experience
“Topical erythromycin continues to be effective for mild-to-moderate inflammatory acne, though combination therapies often yield better results than monotherapy.” - Dermatologist, 8 years experience
“The gastrointestinal side effect profile can be challenging for some patients, but the drug’s broad spectrum and reliability maintain its place in our formulary.” - Clinical Pharmacist, 12 years experience